2,249
Views
2
CrossRef citations to date
0
Altmetric
Hematology

Efficacy and safety of Venetoclax-based regimens in relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trials

, &
Pages 1029-1036 | Received 28 Nov 2022, Accepted 26 Feb 2023, Published online: 13 Mar 2023

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.